Navigation Links
John Theurer Cancer Center hosts New Frontiers in the Management of Solid and Liquid Tumors

HACKENSACK, N.J., (October 10, 2011) John Theurer Cancer Center at Hackensack University Medical Center, one of nation's top 50 best hospitals for cancer, will host the New Frontiers in the Management of Solid and Liquid Tumors on November 3-4 from 7:00am to 4:00pm. This complimentary Continuing Medical Education (CME) program will feature internationally recognized oncologists and hematologists who will provide the latest updates on state-of the-art treatment modalities including novel therapies and new prognostic models in hematological and solid tumors.

"The oncology treatment landscape is rapidly changing," Andre Goy, M.D., M.S., Chairman and Director and Chief of Lymphoma, John Theurer Cancer Center and the program Chair. "This program has been designed to help physicians gain additional insight into how translational research can be applied to the clinic for improved patient outcomes."

Key topics include emerging best practices and ongoing studies in hematological malignancies and solid tumors, the impact of novel therapies in the care of hematology-oncology and solid tumor patients, new modalities in imaging and its best use in cancer patients, biomarkers and new prognostic markers in lymphomas and leukemias, the impact of emerging molecular markers in solid tumors, and the shifting paradigms in the treatment of multiple myeloma. A 15-minute Q&A will follow all presentations.

"This is a great opportunity for physicians and healthcare professionals to hear about the newest research from leading oncology and hematology physicians," Stuart L. Goldberg, M.D., Chief, Leukemia, John Theurer Cancer Center and program Co-Chair. "We are fortunate to have some of the worlds' foremost experts in solid and liquid tumors present information that will guide the development of future therapies."

Featured Speakers and Topics for Thursday, November 3:

  • Volker Diehl, M.D., Professor, University of Cologne, Germany
    Customization: The Treatment of Hodgkin's Disease
  • Jean-Luc Harousseau, M.D., Professor of Hematology, Head, Dept. of Clinical Hematology, Director of the Cancer Center Rene Gauducheau, University of Nantes, France
    Impact of Novel Therapies in the Management of Multiple Myeloma
  • Richard Champlin, M.D., Chair, Dept. of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The Univ. of Texas MD Anderson Cancer Center
    Newest Modalities in Bone Marrow Transplantation
  • Thomas Habermann, M.D., Professor of Medicine, Division of Hematology, Mayo Clinic
    Treatment of Large-Cell Lymphoma
  • Susan O'Brien, M.D., Professor, Dept. of Leukemia, Division of Cancer Medicine, the University of Texas MD Anderson Cancer Center
    Newest Strategies in the Treatment of CML/CLL
  • Myron Czuczman, M.D., Professor Chief, Lymphoma/Myeloma Service, Dept. of Medicine Head, Lymphoma Translational Research Laboratory Dept. of Immunology Roswell Park Cancer Center
    Evolving Management of Follicular Lymphoma

Featured Speakers and Topics for Friday, November 4:

  • Shiladitya Sengupta, M.D., Assistant Professor of Medicine and Health Sciences and Technology, Harvard Medical School, Brigham & Women's Hospital
    Personalized Medicine Approaches in Oncology
  • Christoper Logothetis, M.D., Dept. Chair, Dept. of Genitourinary Medical Oncology, Division of Cancer Medicine, the Univ. of Texas MD Anderson Cancer Center
    Current Landscapes in the Management of Prostate Cancer
  • Christopher Azzoli, M.D., Assistant Member, Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center
    Current Modalities in the Treatment of Lung Cancer
  • Axel Grothey, M.D., Professor of Oncology; Consultant, Medical Oncology, Mayo Clinic
    New Perspectives in GI Malignancies
  • Kevin R. Fox, M.D., Director, Rena Rowan Breast Center, Perelman Center for Advanced Medicine at Penn Medicine
    Newest Approach to Breast Cancer
  • Steven Horwitz, M.D., Assistant Attending, Lymphoma Service, Division of Hematologic Oncology, Memorial Sloan-Kettering Cancer Center
    Managing T-Cell Lymphoma

"We are committed to providing physicians and healthcare providers with the best educational programs to help clinicians manage today's most complicated cases in cancer," said Andrew L. Pecora, M.D., F.A.C.P., C.P.E., Chief Innovations Officer and Professor and Vice President of Cancer Services, John Theurer Cancer Center. "I would like to thank Dr. Goy for spearheading this important conference and the impressive panel of experts for presenting at the John Theurer Cancer Center."


Contact: Amy Leahing
John Theurer Cancer Center

Related medicine news :

1. John Theurer Cancer Center hosts hematologic malignancies program for physicians and patients
2. John Theurer Cancer Center offers breakthrough radiation measurement technology
3. Leading physicians and researchers at the John Theurer Cancer Center present research at ASCO
4. John Theurer Cancer Center experts present new cancer research at ASCO Annual Meeting
5. The John Theurer Cancer Center recognizes medical physics team for safety track record
6. John Theurer Cancer Center and LLS host panel discussion with leading hematologists
7. John Theurer Cancer Center first cancer center in N.J. to acquire new radiotherapy system
8. John Theurer Cancer Center to present innovative research at 2 surgical meetings
9. The John Theurer Cancer Center to unveil 40 presentations at the 52nd ASH Annual Meeting
10. John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers
11. Oncology basic research director at John Theurer Cancer Center continues transplantation research
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... The workstation boundaries for ... IMAGE Information Systems launches MED-TAB™ -- the world’s first portable DICOM-calibrated medical image ... 29 to December 4, 2015. , MED-TAB is expected to change teleradiology ...
(Date:12/1/2015)... ... , ... The importance of volumetric breast density assessment for ... abstracts accepted for presentation here, at the 101st Annual Radiology Society of North ... of Volpara Solutions’ quantitative breast imaging software tools for providing breast imaging and ...
(Date:12/1/2015)... ... December 01, 2015 , ... For ... That is why Hollister Incorporated has launched the VaPro Plus Pocket™ touch free ... in the VaPro touch free catheter portfolio,” said Michael Gresavage, Vice President North ...
(Date:12/1/2015)... ... December 01, 2015 , ... SAN FRANCISCO, Calif. (December 1, ... organization has awarded Education and Developmental Therapies (EDT), an Applied Behavior Analysis (ABA) ... exceptional special needs providers that excel in synthesizing the areas of clinical quality, ...
(Date:12/1/2015)... ... December 01, 2015 , ... McLean, ... been awarded a fixed price per sprint agile development contract to support the ... million over five years, provides software engineering, infrastructure, as well as operations and ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... During the recent 2015 Transcatheter Cardiovascular ... CA , Medinol Ltd. continued to introduce ... a satellite symposium, "The BioNIR eDES: The Role ... a renowned physician panel discussed the key attributes ... Stent System and the Medinol eDES Coronary Stent ...
(Date:12/1/2015)... YORK , Dec. 1, 2015 Relmada Therapeutics, ... the treatment of chronic pain, announced today that the company ... will be held December 1-3 at the Luxe Sunset Boulevard ... Sergio Traversa , CEO of Relmada Therapeutics, will present on ... Eastern Time). . Please register at least ...
(Date:12/1/2015)... Dec. 1, 2015  InCarda Therapeutics, Inc. (InCarda), a ... of therapies for cardiovascular conditions via the inhalation route, ... in Australia . InCarda is planning ... Australia in the first half of ... medical centers in Adelaide and ...
Breaking Medicine Technology: